Autonomix Medical, Inc. (AMIX) Gets FDA Feedback Supporting 510(k) Path

Autonomix said FDA pre-submission feedback supports a Class II substantial-equivalence 510(k) pathway for its standalone sensing platform, with potential U.S. clearance targeted in approximately 15 months, subject to development, validation and FDA review.Material DetailsContext by AI AnalystEarly…